New Data Available on KEVEYIS for PPP

In a news release from mid-July, 2021, biopharmaceutical company Strongbridge Biopharma plc ("Strongbridge") shared the publication of new post hoc analyses regarding KEVEYIS (dichlorphenamide) for patients with Primary Periodic Paralysis…

Continue Reading New Data Available on KEVEYIS for PPP